- June 02, 2026
-
Notice Regarding Suspension of Production and Dissolution of HIROSHIMA MORINAGA MILK INDUSTRY CO., LTD.
- June 01, 2026
-
Human-Resident Bifidobacterium longum BB536 May Improve Diarrhea-Related QOL Scores and Reduce Body-Odor-Related Metabolites in Male Athletes Consuming a High-Protein Diet
- May 11, 2026
-
Bifidobacterium infantis M-63 May Support Bowel Habits and the Gut Environment in Infants and Toddlers During the Weaning Period
- March 27, 2026
-
Morinaga Milk Group Integrated Report 2025 Receives the Award for Excellence at the 5th NIKKEI Integrated Report Award 2025
- March 25, 2026
-
Notice Regarding Results and Completion of Acquisition of Treasury Stock and Determination of the Number of Shares to Be Cancelled (Acquisition of Treasury Stock under the Articles of Incorporation pursuant to Article 165, Paragraph 2 of the Companies Act and Cancellation of Treasury Stock pursuant to Article 178 of the Companies Act)
- March 13, 2026
-
Notice Regarding Determination of Basic Policy and Beginning of Preparations for Absorption-Type Merger of Wholly Owned Subsidiary Morinaga Milk Industry Sales Co., Ltd.
- March 13, 2026
-
Notice Concerning Cancellation of Treasury Stock
- January 30, 2026
-
Notice Regarding Changes to Volume and Repricing of Certain Products
- December 18, 2025
-
Notice Regarding the Appointment of a New Chairman, MILEI GmbH
- October 14, 2025
-
Morinaga Milk to begin sales in overseas markets of “Happiness Lactobacillus®,” which has been carefully selected from among the thousands of strains of probiotics/postbiotics owned by the Company, under the product name “LAC-Living+,” from December 2025
